Institute of Oral Science, Chung Shan Medical University, Taichung City 402, Taiwan.
Department of Stomatology, Chung Shan Medical University Hospital, Taichung City 402, Taiwan; School of Dentistry, Chung Shan Medical University, Taichung City 402, Taiwan.
Mater Sci Eng C Mater Biol Appl. 2020 May;110:110727. doi: 10.1016/j.msec.2020.110727. Epub 2020 Feb 4.
Calcium silicate cement has attracted much attention for bone defect repair and regeneration due to its osteogenic properties. Biomaterial-associated infections and washout have become a common clinical problem. In order to enhance the antibacterial and washout performance of calcium silicate cement to meet clinical needs, different types of chitosan, including chitosan polysaccharide (CTS), quaternary ammonium chitosan (QTS), and chitosan oligosaccharide (COS), as a liquid phase were added to the calcium silicate powder. The physicochemical properties, in vitro bioactivity, antibacterial efficacy, and osteogenic effects (MG63 cells) of the cement were evaluated. Antibacterial activity was conducted with Gram-negative Escherichia coli (E. coli) and a Gram-positive Staphylococcus aureus (S. aureus) bacteria. The amount of intracellular reactive oxygen species (ROS) produced in the bacteria cultured with the chitosan solution was also detected. The experimental results showed that the chitosan additive did not affect the crystalline phase of calcium silicate cement, but increased the setting time and strength of the cement in a concentration-dependent manner. Within the scope of this study, CTS and QTS solutions with a concentration of not <1 wt% improved the washout resistance of the control cement, while the COS solutions failed to strengthen the cement. When soaked in simulated body fluid (SBF) for 1 day, all cement samples formed apatite spherules. As the soaking time increased, the diametral tensile strength of all cements decreased and the porosity increased. The assays of MG63 cell function showed lower osteogenic activity of osteoblastic cells grown on the surfaces of the chitosan-incorporated cements in comparison with the control cement without chitosan. At the same 1% concentration, compared with QTS and COS cement, CTS cement had lower cell attachment, proliferation, differentiation, and mineralization. Conversely, the CTS cement resulted in the highest bacteriostasis ratio among the three hybrid cements against two bacteria. The ROS production followed the order of CTS > QTS > COS at the same 1% concentration. In conclusion, calcium silicate cement with 1% QTS may be a viable candidate for bone defect repair in view of anti-washout performance, setting time, antibacterial activity, and osteogenic activity shown in this study.
硅酸钙水泥由于其成骨特性而受到广泛关注,可用于骨缺损修复和再生。生物材料相关的感染和冲洗已经成为一个常见的临床问题。为了提高硅酸钙水泥的抗菌和冲洗性能,以满足临床需求,不同类型的壳聚糖,包括壳聚糖多糖(CTS)、季铵化壳聚糖(QTS)和壳聚糖寡糖(COS),作为液相被添加到硅酸钙粉末中。评估了水泥的物理化学性质、体外生物活性、抗菌效果(MG63 细胞)和成骨效果。使用革兰氏阴性大肠杆菌(E. coli)和革兰氏阳性金黄色葡萄球菌(S. aureus)细菌进行抗菌活性测试。还检测了用壳聚糖溶液培养的细菌中细胞内活性氧(ROS)的产生量。实验结果表明,壳聚糖添加剂不影响硅酸钙水泥的晶体相,但以浓度依赖的方式增加水泥的凝固时间和强度。在本研究范围内,浓度不低于 1wt%的 CTS 和 QTS 溶液提高了对照水泥的抗冲洗性能,而 COS 溶液未能增强水泥的强度。在模拟体液(SBF)中浸泡 1 天后,所有水泥样品均形成了磷灰石小球。随着浸泡时间的延长,所有水泥的直径拉伸强度降低,孔隙率增加。MG63 细胞功能检测表明,与不含壳聚糖的对照水泥相比,在壳聚糖掺入的水泥表面生长的成骨细胞的成骨活性较低。在相同的 1%浓度下,与 QTS 和 COS 水泥相比,CTS 水泥的细胞黏附、增殖、分化和矿化能力较低。相反,在三种混合水泥中,CTS 水泥对两种细菌的抑菌率最高。在相同的 1%浓度下,ROS 的产生顺序为 CTS > QTS > COS。综上所述,考虑到本研究中显示的抗冲洗性能、凝固时间、抗菌活性和成骨活性,含 1% QTS 的硅酸钙水泥可能是骨缺损修复的可行候选物。